The crypto regulatory story traders were betting on just died — the Clarity Act failed its Senate vote, and companies whose business depends on clear U.S. crypto rules got hit immediately. This wasn't a market-wide move: it was crypto-specific selling, wh

Verdict: the short thesis has the news behind it, but the entries are not live yet

The strongest argument for this short is that the catalyst failure is confirmed and correlated with distribution: the Clarity Act died in the Senate per CoinDesk, ARK trimmed Circle before the vote per Yahoo Finance, and COIN's 13F cohort for the period ended 2026-06-30 shows roughly $12.8M of net open-market selling across 8 holders. The fundamentals add fuel — COIN's operating margin slid 7.8 points quarter over quarter to -9.3% in Q2 2026, with net margin at -29.5% — and none of the three names pays a dividend to hold buyers in. The strongest argument against is that the counter-evidence is genuinely solid: Coinbase earned $1.3B in FY2025 with $2.4B of operating cash flow and $11.3B of cash, Circle posted a $55.3M Q1 2026 profit, and Galaxy's operating margin just turned positive — these are reset candidates, not broken companies, and a 2.5% stop on stocks with 60-80% historical drawdowns invites noise stop-outs. The backtest also rests on a single completed run: the COIN 12-month window (6 trades, 67% win rate, +11.3%, 20.1% max drawdown), with the 24- and 60-month and CRCL/GLXY runs not evaluable due to market-data gaps. Right now no entry set is live — COIN is $6.26 below its Bollinger midline, RSI is under 50 but MACD is still positive — so the disciplined move is to wait for a bounce into resistance that then rejects. The verdict flips to standing down the moment a Clarity Act revote is scheduled.

Trade now

This is a sell-the-bounce-at-resistance short on COIN, CRCL and GLXY, and as of the latest close none of the three entry sets is fully live. On COIN ($172.11), price needs a day's high back at or above the 21-day EMA at $175.62 and the 20-day Bollinger midline at $178.37 — about $3.51 and $6.26 away. RSI at 45.3 has already crossed below 50, but MACD at 4.32 is still positive and needs to fall below 0. CRCL ($86.30) is similarly close: $2.11 below its EMA at $88.41 and $3.99 below the midline at $90.29, with RSI at 43.2 under 50 and MACD at 4.81 still above zero. GLXY ($22.29) is furthest along on momentum — MACD at 0.35 is nearly negative and RSI sits at 36.1 — but price is $1.67 below the EMA at $23.96 and $1.82 below the midline at $24.11. So "wait" means waiting for a bounce into resistance that then gets rejected: a high at or above both reference bands, an RSI cross under 50, and a negative MACD histogram on the same signal. If any leg triggers, the strategy risks roughly 2.5% per position with a hard stop at a 2.5% loss, a 5% take profit (about 2:1 reward-to-risk), and a 45-bar time stop. On the evidence, the COIN leg of this setup was backtested over the last 12 months: 6 trades, a 67% win rate, an 11.3% return and a 20.1% maximum drawdown — the completed stats behind the immediate plan. No robust parameter setup was established beyond the frozen rules, so treat the live levels above as the operative ones. The invalidation story is already half-formed: price is below the Bollinger midline on all three names, which is the bearish context the thesis expects — the idea argues bounces get sold until a revote materializes. What would kill the short is a close at or above the upper Bollinger band with RSI above 60 — on COIN, a close near $180 with momentum turning hot. One scope limitation: the 24- and 60-month backtest windows could not be completed for CRCL and GLXY because of market-data gaps, so the 12-month COIN window is the only completed run. Position sizing is capped at 25% per name.

Regulatory Catalyst Gone, Erosion Already on the Tape

The idea's core claim — that the Clarity Act's Senate failure removes the regulatory catalyst these names trade on — lands on fundamentals that were already deteriorating before the vote. Coinbase's operating margin swung from -1.5% in Q1 2026 to -9.3% in Q2 2026, a deterioration of 7.8 percentage points, while net margin slipped to -29.5% and revenue fell from $1.41B in Q1 to $1.22B in Q2 2026, down from $1.78B in Q4 2025. Per the CoinDesk report on the Senate rejection, crypto stocks sold off immediately and specifically — this is a crypto-specific repricing, not a macro one, so it can continue regardless of what the Fed does. The ownership tape supports the 'more supply to come' leg of the thesis. ARK trimmed its Circle stake before the vote, and Circle sank 8% on the news per the Yahoo Finance piece — sophisticated money positioning ahead of the event is exactly the footprint the idea argues signals continued distribution. Coinbase's Form 13F cohort for the period ended 2026-06-30 shows net open-market insider selling of roughly $12.8M across 8 reporters. Circle's share count has climbed from 222.5M to 247.6M in five quarters, and Galaxy's free cash flow ran -$1.5B for FY2025 — dilution and cash burn mean bounces meet real sellers, not just sentiment. None of these names pays a dividend, so there is no income floor holding buyers in during a catalyst vacuum — the thesis's 'bounces get sold' framing is consistent with the shareholder base being purely catalyst-driven. The backtest evidence is a completed 12-month daily run on…

Scores

• Conviction score breakdown: 51
• Thesis support: 70
• Trade readiness: 35
• Risk quality: 40
• Backtest evidence: 45
• Fundamentals trend: 65

Watch items

• COIN — MACD (12,26,9) histogram
• COIN — Daily high vs 21-day EMA / Bollinger midline
• CRCL — MACD (12,26,9) histogram
• CRCL — Daily high vs 21-day EMA / Bollinger midline
• GLXY — MACD (12,26,9) histogram
• GLXY — Daily high vs 21-day EMA / Bollinger midline
• COIN — Insider net open-market activity
• COIN — Position invalidation signal